Home Newsfeeds Sidoti & Co. Downgrades Co-Diagnostics to Neutral, Announces $5 Price Target

Sidoti & Co. Downgrades Co-Diagnostics to Neutral, Announces $5 Price Target

Sidoti & Co. analyst James Sidoti downgrades Co-Diagnostics (NASDAQ:CODX) from Buy to Neutral and announces $5 price target.

byBenzinga Newsdesk

August 12, 2022

1 minute read

Sidoti & Co. analyst James Sidoti downgrades Co-Diagnostics (NASDAQ:CODX) from Buy to Neutral and announces $5 price target.

Analyst Ratings

11 Analysts Have This to Say About Honeywell Intl

By Benzinga Insights

November 14, 4:22 PM

Honeywell Intl (NASDAQ:HON) has observed the following analyst ratings within the last quarter:

HON

The Dixie Group Q3 EPS $(0.55) Down From $0.35 YoY, Sales $71.76M Miss $101.56M Estimate

By Benzinga Newsdesk

November 3, 11:52 AM

The Dixie Group (NASDAQ:DXYN) reported quarterly losses of $(0.55) per share. This is a 257.14 percent decrease over earnings of $0.35 per share from the same period last year. The company reported quarterly sales of

DXYN

IBM’s Double-Digit Growth In TP And Data & AI Not Sustainable, Predicts Analyst

By Nabaparna Bhattacharya

July 20, 3:07 PM

BMO Capital Markets analyst Keith Bachman reiterated the Market Perform rating on International Business Machines Corporation (NYSE: IBM),

IBM

Business Events In Miami, Florida This Week: Cannabis Conference, Psychedelics Investment And Science Summit, Lexy Panterra And More

By Javier Hasse

April 10, 1:43 PM

Are you looking for events in Miami, Florida this week? Look no further!

Sidoti & Co. Downgrades Co-Diagnostics to Neutral, Announces $5 Price Target

Related Posts

11 Analysts Have This to Say About Honeywell Intl

The Dixie Group Q3 EPS $(0.55) Down From $0.35 YoY, Sales $71.76M Miss $101.56M Estimate

IBM’s Double-Digit Growth In TP And Data & AI Not Sustainable, Predicts Analyst

Business Events In Miami, Florida This Week: Cannabis Conference, Psychedelics Investment And Science Summit, Lexy Panterra And More